Gladstone Investment (GAIN) Q4 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants David Gladstone - Founder, Chairman & CEOMichael Licalsi - General Counsel & SecretaryDavid Dullum - PresidentTaylor Ritchie - CFOMickey Schleien - MD - Equity ResearchErik Zwick - Managing Director, Equity Research Operator and welcome to Gladstone Investment Corporation Fourth Quarter and Year End Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer session w ...

DarioHealth (DRIO) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Kat Parrella - Investor Relations ManagerErez Raphael - Chief Executive OfficerLara Dodo - Chief Operations OfficerCharles Rhyee - Managing DirectorDavid Grossman - Managing Director Operator morning, ladies and gentlemen, and welcome to the DarioHealth First Quarter twenty twenty five Results Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answe ...

Cellebrite DI (CLBT) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Andrew Kramer - Vice President-Investor RelationsThomas Hogan - CEODana Gerner - CFOTomer Zilberman - Equity Research AssociateMarcus Jewell - Global Chief Revenue OfficerShaul Eyal - Managing Director - Equity Research Conference Call Participants Jeff Van Rhee - Partner & Senior Analyst - Equity ResearchMike Cikos - Senior AnalystJonathan Ho - Research AnalystEric Martinuzzi - Senior Research Analyst Operator Welcome ...

Cellebrite DI (CLBT) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Andrew Kramer - Vice President-Investor RelationsThomas Hogan - CEODana Gerner - CFOTomer Zilberman - Equity Research AssociateMarcus Jewell - Global Chief Revenue OfficerShaul Eyal - Managing Director - Equity Research Conference Call Participants Jeff Van Rhee - Partner & Senior Analyst - Equity ResearchMike Cikos - Senior AnalystJonathan Ho - Research AnalystEric Martinuzzi - Senior Research Analyst Operator Welcome ...

ARS Pharmaceuticals (SPRY) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Justin Chakma - Chief Business OfficerRichard Lowenthal - Co Founder, President, CEO & DirectorEric Karas - Chief Commercial OfficerKathleen Scott - Chief Financial OfficerRyan Deschner - Vice President - Equity ResearchJosh Schimmer - Managing DirectorLouise Chen - Managing Director Conference Call Participants Roanna Ruiz - Senior Managing Director, Biotechnology AnalystLachlan Hanbury-Brown - Biotech Equity Res ...

Allurion Technologies (ALUR) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants None - ExecutiveShantanu Gaur - Founder & CEOJoshua Jennings - Managing Director Conference Call Participants Jason Wittes - Managing Director & Senior Research AnalystNone - AnalystMichael Toomey - US Medtech Analyst Operator Hello, and welcome to the Allurion First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question an ...

Alico (ALCO) Q2 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants John Mills - Managing PartnerJohn Kiernan - President and Chief Executive OfficerBrad Heine - CFOBrandon Rogers - Equity Research Associate Operator Morning, and welcome to Aleco's Second Quarter twenty twenty five Earnings Call. Currently, all participants are in a listen only mode. As a reminder, today's conference is being recorded. I would now like to turn the call over to your host, John Mills, Managing Partner at ICR. Joh ...

ADC Therapeutics (ADCT) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Marcy Graham - Investor Relations & Corporate Affairs OfficerAmeet Mallik - CEOMohamed Zaki - Chief Medical OfficerJose Carmona - Chief Financial OfficerSudan Loganathan - Managing Director Conference Call Participants None - AnalystEric Schmidt - Biotechnology AnalystGregory Renza - Senior Biotechnology Analyst Operator morning, ladies and gentlemen, and welcome to ADC Therapeutics First Quarter twenty twenty five E ...

Waldencast (WALD) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Speaker0 Good day, and welcome to the Waldencast First Quarter twenty twenty five Earnings Call. All participants will be in listen only mode. A question and answer session will follow the formal presentation. Please note that this event is being recorded. I will now hand you over to Alison Malkin, Partner ICR. You may proceed. Speaker1 Thank you and welcome to the Weldon Cast plc first quarter fiscal twenty twenty five earnings call. Here wit ...

Financial Data and Key Metrics Changes - For Q1 2025, the company reported net income of $18.2 million, which includes a fair value adjustment of $21.2 million related to contingent earn-out liability [18] - Revenue for Q1 2025 was $87 million, a decrease of $13.8 million or 13.7% from $100.8 million in Q1 2024, primarily due to lower home closings [18][19] - Home closings totaled 252 homes, down from 311 homes in the prior year period [19] - The average sales price for production built homes was approximately $345,000, a 2.9% increase compared to $335,000 in Q1 2024 [19] - Gross profit for Q1 2025 was $14.1 million, down $2 million or 12.4% from $16.1 million in the prior year [20] - Gross margin improved slightly to 16.2% from 16% [20] Business Line Data and Key Metrics Changes - The company delivered 252 homes in Q1 2025, with an average sales price of $345,000, generating home sales revenue of $87 million [4] - Net new orders for Q1 2025 were 296 homes, down from 384 homes in the prior year period [19] - The backlog as of March 31, 2025, stood at 201 homes, representing approximately $75.3 million in value [20] Market Data and Key Metrics Changes - The company noted that affordability continues to be an issue for buyers, necessitating the use of financing incentives [13] - April orders were up 6% year over year, indicating a positive trend in demand [10][13] Company Strategy and Development Direction - The company has undertaken a product refresh and direct cost reduction initiative to improve competitive positioning and profitability [5][6] - A strategic shift towards presold homes is being emphasized, moving away from a high spec home strategy [8][9] - The company plans to open 10 new communities in Q2 and 18 communities in Q3, which are expected to boost sales efforts [15][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the long-term prospects for markets in the Carolinas and Georgia due to favorable housing fundamentals [10] - The company is adapting to shifting market dynamics and remains focused on execution and capital allocation [22] - Management noted that the spring selling season started slowly but showed momentum exiting the quarter into April [22] Other Important Information - The company controlled approximately 7,500 lots as of March 31, 2025, positioning it for future growth [22] - Selling, general and administrative expenses for Q1 were $16.2 million, with adjusted SG&A totaling $14.2 million or 16.3% of revenue [21] Summary of Q&A Session - There were no questions during the Q&A session, and the call concluded with management expressing optimism about the future of the company [24][25]